Walter Schmidt
Directeur/Bestuurslid bij Advantage Therapeutics, Inc.
Profiel
Walter Schmidt currently works at ADvantage Therapeutics, Inc., as Director & Director-mRNA Division.
Actieve functies van Walter Schmidt
| Bedrijven | Functie | Begin |
|---|---|---|
Advantage Therapeutics, Inc.
 Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | Health Technology |
